Onkure Therapeutics Inc expected to post a loss of $1.08 a share - Earnings Preview

Onkure Therapeutics

08/11/2024 16:32

* Onkure Therapeutics Inc  OKUR.OQ   OKUR.O  is expected
to show
no change in quarterly revenue when it reports  results  for the
period ending December 31 2024
    * 
    * ​LSEG's mean analyst estimate for Onkure Therapeutics Inc
is for
a loss of $1.08 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 47.1%
in the last three months. ​
    * Wall Street's median 12-month price target for Onkure
Therapeutics Inc is $35.00​, above​ its last closing price
of $17.19. ​​​

This summary was machine generated November 8 at 16:31 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)